Free Trial

Ryan Deschner - Raymond James Financial Analyst Performance

This page shows the methodology used to calculate Ryan Deschner's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
7/24/2025$33.80$122.00Strong-Buy???%???%
Tvardi Therapeutics, Inc. stock logo
TVRD
Tvardi Therapeutics
7/14/2025$27.34$62.00Outperform???%???%
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
5/16/2025$3.95$4.00Hold???%???%
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
5/9/2025$17.88$52.00Outperform???%???%
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5/9/2025$15.44$29.00Strong-Buy???%???%
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
3/10/2025$4.30$29.00Strong-Buy???%???%
Ardelyx, Inc. stock logo
ARDX
Ardelyx
2/21/2025$5.29$13.00Strong-Buy???%???%


Return to Analyst Rankings